The widespread distribution of GLP-1 receptors means that activating them produces ripple effects across multiple organ systems, and each new study reveals additional potential applications
Patients taking Ozempic alongside insulin or sulfonylureas should monitor for hypoglycaemia if their appetite or food intake is reduced, and may need medication adjustments
In addition to decreasing the fluidity of the platelet membrane and promoting platelet aggregation, coagulation factors and PAI-1 (plasminogen activator inhibitor-1) will also increase under the condition of hyperglycemia, breaking the balance of coagulation and fibrinolysis and promoting thrombosis
In the U.S., an estimated 5.1% of non-Hispanic White patients with obesity use GLP-1s, compared to 4.5% of Asian patients, 4.1% of non-Hispanic Black patients, 4.0% of Native American patients, and 3.7% of Hispanic patients
Coverage varies widely by plan and program
As of late 2024, the agency declared the tirzepatide shortage resolved, which limits the legal grounds for continued compounding